2022-11-28 16:42:01

Shenyang Dynamics | Nuclear Gene Signed and Settled in CEC Optics Valley Information Port, Both Parties Jointly Promote the Upgrade of Shenyang Biomedical Industry

On August 7, Nuclear Gene Technology Co., Ltd. settled in the information port of CEC Optical Valley, and the signing ceremony was held at the CEC Optical Valley Exhibition Center. Shao Xiantao, Financial Director of Nucleus Gene Group, He Wei, Marketing Director, Li Chaoxue, General Manager of Nucleus Gene Shenyang Branch, Yang Yulong, Executive General Manager of Shenyang Optics Valley Joint Development Co., Ltd., Zeng Jianzhong, Senior Deputy General Manager and other enterprise representatives attended the meeting.

Shenyang Dynamics | Nuclear Gene Signed and Settled in CEC Optics Valley Information Port, Both Parties Jointly Promote the Upgrade of Shenyang Biomedical Industry

▲ Both parties sign a contract

Shenzhen Nuclear Gene Technology Co., Ltd. (hereinafter referred to as Nuclear Gene) is a global leading genomics research institution, and also a bio high-tech enterprise that provides professional gene detection and research services for major domestic scientific research institutions and research institutions. It has successively carried out in-depth technical exchanges and cooperation with a number of genetic research institutions and enterprises at home and abroad. Over the past decade, it has made a series of breakthroughs in technical research, established eight world leading technology platforms, and always kept pace with international outstanding enterprises. At present, with more than 4000 gene patents, nuclear gene ranks 4th in China and 10th in the world. In the competition of gene industry, it further seized the market opportunity and consolidated the position of industry leader.

Shenyang Dynamics | Nuclear Gene Signed and Settled in CEC Optics Valley Information Port, Both Parties Jointly Promote the Upgrade of Shenyang Biomedical Industry

▲ Exchange between enterprise representatives of both parties

2020 is a year full of challenges for the whole world. In the face of the sudden "Black Swan Event", while adhering to high-quality investment attraction, CEC Optics Valley Information Port grasped the pulse of the times, turned the crisis into an opportunity with the thinking of breaking the situation, and took the advantages of the biological medicine industry in Shenbei New District as the main grasp. At the same time, it aimed at the pain points of the industry, found the hot spots of the industry, explored the opportunities of the industry, and increased investment attraction to the general health and medical testing industries. "Nuclear gene" is also the fourth biomedical and medical testing enterprise settled in the CEC Optical Valley Information Port after "Mike Biology", "Shanyujun Biology" and "Everyone's Medical Testing", laying the foundation for the park to build an industrial cluster.

At the signing ceremony, Yang Yulong, the general manager, said that CEC Optics Valley Information Port would actively promote and give full play to the successful operation experience and resource integration advantages of Optics Valley Bio City, relying on its own enterprise advantages, to provide assistance for the future development of nuclear gene.

Director Shao Xiantao also said that the settlement in the information port of CEC Optical Valley is an important part of the future development of nucleon gene, which is a milestone. He hoped that the two enterprises could work together to create a win-win situation in the future.

Shenyang Dynamics | Nuclear Gene Signed and Settled in CEC Optics Valley Information Port, Both Parties Jointly Promote the Upgrade of Shenyang Biomedical Industry

▲ Group photo of enterprise representatives of both parties

Shenzhen Nuclear Gene Technology Co., Ltd., founded in 2012, is a high-tech enterprise integrating gene technology research and development and market application. It is divided into four sectors: judicial identification, medical testing, health management and scientific research services. Nuclear Gene adheres to the core concept of "gene technology serves people", always taking customer experience as the starting point and market demand as the research and development orientation. We will strive to be a "gene testing company around you", so that gene technology can truly enter Chinese families and benefit the public. It has successively established a number of domestic leading gene research and development platforms with Peking Union Medical University, Wuhan University, Fudan University, China Medical University and other universities, and has a number of international level scientific research achievements, providing professional gene detection and research services for domestic major research institutions, hospitals and research institutions.

Source/Shenyang Company

Edited by Huang Ruimin

. Vision/Zhang Lingzhi.